Materia Medica of New and Old Homeopathic Medicines

David S. Riley’s interest in the research and subsequently the history and methodology of homeopathic drug provings began with his medical school training in 1979 and a residency in Internal Medicine. He was exposed to homeopathy in 1988 followed by study at the Hahnemann College of Homeopathy in Albany, California. He has investigated the interplay between contemporary research methods and the research methods associated with homeopathic drug provings. Dr Riley has developed research tools for data collection, symptom selection criteria and blinding; primarily to address the risk of bias.The homeopathic drug provings published here are the result of this work. For the 3 rd edition twelve homeopathic drug provings, conducted by a number of internationally renowned proving directors, have been added. These homeopathic drug provings all follow good clinical practice (GCP) research guidelines and incorporate the guidelines suggested by Dr Samuel Hahnemann more than 200 years ago. Foreword to the 3rd Edition 6 Foreword to the 2nd Edition 9 Contents 12 About the Editor and Contributors 18 1 Homeopathic Drug Provings 21 References 23 2 Acidum alpha-ketoglutaricum 24 3 Acidum alpha-lipoicum 28 4 Acidum ascorbicum 30 5 Acidum cis-aconiticum 33 6 Acidum citricum 36 7 Acidum fumaricum 38 8 Acidum malicum 41 9 Acidum oroticum 44 10 Acidum succinicum 47 11 Adenosinum monohydrogen phosphoricum (cAMP) 49 12 Adenosinum triphosphoricum dinatrium (ATP) 52 13 Agnus castus 55 14 Anthrachinonum 58 15 Arteria suis 61 16 Ascophyllum nodosum 63 17 Bacterium coli nosode 65 18 Baryta oxalsuccinicum 68 19 Benzochinonum, para- 71 20 Bryonia alba 73 21 Bryonia dioica 76 22 Calendula officinalis 79 23 Cardiospermum halicacabum 82 24 Cartilago suis 85 25 Caulophyllum thalictroides 88 26 Cerebrum suis 90 27 Coenzymum A 93 28 Colocynthis 95 29 Cuprum formicicum 98 30 Cyanocobalaminum 100 31 Cysteinum 104 32 Discus intervertebralis suis 107 33 Embryo suis 111 34 Fucus vesiculosus 114 35 Fumaria officinalis 117 36 Funiculus umbilicalis suis 119 37 Galphimia glauca 122 38 Geranium robertianum 124 39 Glandula suprarenalis suis 127 40 Glyoxalum 130 41 Hepar suis 132 42 Hydrochinonum 135 43 Hypophysis suis 138 44 Hypothalamus suis 142 45 Kalium tetraiodobismutatum 146 46 Levothyroxinum 148 47 Luffa operculata 150 48 Magnesium gluconicum 153 49 Magnesium oroticum 156 50 Mahonia aquifolium 158 51 Manganum phosphoricum 161 52 Medulla ossis suis 164 53 Methylglyoxalum 167 54 Mucosa nasalis suis 169 55 Mucosa suis 171 56 Myosotis arvensis 175 57 Nadidum (NADH) 177 58 Naphthochinonum 179 59 Natrium oxalaceticum 182 60 Natrium pyruvicum 185 61 Nicotinamidum 187 62 Okoubaka aubrevillei 190 63 Oleander 192 64 Oleum Pini 194 65 Oxalis acetosella 196 66 Pancreas suis 199 67 Pelargonium sidoides 202 68 Placenta suis 204 69 Pyridoxinum hydrochloricum 207 70 Riboflavinum 210 71 Sinusitisinum 213 72 Staphylococcus nosode 216 73 Streptococcus nosode 218 74 Symphytum officinale 221 75 Terebinthina laricina 224 76 Thiaminum hydrochloricum 226 77 Tormentilla 229 78 Trichinoylum 232 79 Tuba uterina suis 234 80 Ubichinonum 238 81 Urtica urens 243 82 Uterus suis 246 83 Vena suis 249 84 Veronica officinalis 253 85 Zincum aceticum 256 86 Zincum gluconicum 258 Appendix 1: Overview of Provings 262 Appendix 2: Register of Synonyms 271 References 284 Materia Medica of New and Old Homeopathic Medicines David S. Rileys interest in the research and subsequently the history and methodology of homeopathic drug provings began with his medical school training in 1979 and a residency in Internal Medicine. He was exposed to homeopathy in 1988 followed by study at the Hahnemann College of Homeopathy in Albany, California. He has investigated the interplay between contemporary research methods and the research methods associated with homeopathic drug provings. Dr Riley has developed research tools for data collection, symptom selection criteria and blinding; primarily to address the risk of bias. The homeopathic drug provings published here are the result of this work. For the 3rd edition twelve homeopathic drug provings, conducted by a number of internationally renowned proving directors, have been added. These homeopathic drug provings all follow good clinical practice (GCP) research guidelines and incorporate the guidelines suggested by Dr Samuel Hahnemann more than 200 years ago